Nomura
http://www.nomura.com/Nomura (NYSE: NMR) is a global investment banking and securities firm. The firm’s operations include Domestic Retail, Global Markets, Global Investment Banking, Global Merchant Banking, and Asset Management. Nomura is headquartered in Tokyo, Japan.
Nomura is represented in the Americas by Nomura Holding America (NHA). NHA’s major divisions are Fixed Income, Investment Banking, Equities and Asset Management.
View Older Stories View More Recent Stories
-
China's big cities, from Dalian to Shenzhen, ramp up COVID curbs
-
Form 4 MSP Recovery, Inc. For: Aug 22 Filed by: NOMURA SECURITIES INTERNATIONAL INC
-
Cowen Continues To Build Leading Cross-Asset Team With Four Significant Hires
-
Cowen Continues To Build Leading Cross-Asset Team With Four Significant Hires
-
Germany's football body to hire Deutsche Bank for media rights sale - Bloomberg News
-
China steps up easing, cuts lending benchmarks to revive faltering economy
-
Archegos tried to lull banks before $36 billion firm collapsed - US prosecutors
-
PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001, Its Patented, Orally Available Version of Cepharanthine for Oncology and Infectious Diseas
-
Form 6-K NOMURA HOLDINGS INC For: Aug 19
-
China set to lower lending benchmarks Monday to revive wobbly economy
-
Orchid Island Capital (ORC) Announces 5:1 Reverse Stock Split
-
Orchid Island Capital Announces One-for-five Reverse Stock Split, August 2022 Monthly Dividend and July 31, 2022 RMBS Portfolio Characteristics
-
Form 13F-HR/A NOMURA HOLDINGS INC For: Jun 30
-
Chinese vice premier urges greater effort to boost consumption
-
China central bank, under pressure to ease, is hemmed-in by inflation, Fed jitters
-
Exclusive-China's EVE to supply BMW with large Tesla-like cylindrical batteries in Europe -sources
-
SRI International Launches Commercialization Group, Announces New President
-
SMBC Further Strengthens Real Estate, Gaming & Leisure Banking Practice with Two New Senior Hires
-
Core BTS Announces Conference Dedicated to Digital Transformation
-
SELLAS Life Sciences (SLS) Appoints Katherine Bach Kalin to its Board
-
SELLAS Life Sciences’ Announces Election of Katherine Bach Kalin to its Board of Directors
-
India inflation may remain elevated despite July dip – analysts
-
Crane Co. (CR) to Divest Legacy Asbestos Liabilities
-
Crane Holdings, Co. Announces Transaction to Divest Legacy Asbestos Liabilities
-
Form 13F-NT NOMURA SECURITIES INTERN For: Jun 30
-
Form 13F-NT NOMURA SECURITIES CO For: Jun 30
-
Form 13F-NT NOMURA INTERNATIONAL For: Jun 30
-
Form 13F-NT NOMURA GLOBAL FINANCIAL For: Jun 30
-
Form 13F-HR NOMURA HOLDINGS INC For: Jun 30
-
Goldman, Morgan Stanley seek to end investors' Archegos-linked lawsuits
-
JVCKenwood Corp (6632:JP) PT Raised to JPY210 at Nomura/Instinet
-
Hokuetsu Corporation (3865:JP) PT Raised to JPY680 at Nomura/Instinet
-
China unexpectedly cuts key rates as economic data disappoints
-
Form 13F-NT Nomura Asset Management For: Jun 30
-
Form 13F-NT NOMURA ASSET MANAGEMENT For: Jun 30
-
Form 13F-NT Nomura Asset Management For: Jun 30
-
Form 13F-NT Nomura Islamic Asset For: Jun 30
-
Form 13F-HR NOMURA ASSET MANAGEMENT For: Jun 30
-
Form 13F-NT Nomura Asset Management For: Jun 30
-
Form 13F-NT Nomura Asset Management For: Jun 30
-
Form ABS-15G NOMURA ASSET ACCEPTANCE For: Jun 30
-
Form ABS-15G Nomura Home Equity Loan, For: Jun 30
-
Form 6-K NOMURA HOLDINGS INC For: Aug 12
-
Sosei Heptares Operational Highlights and Consolidated Results for the Second Quarter and First Half of 2022
-
Netsmart Announces the Skilled Nursing Industry’s Only Data Analytics Solution with a Complete View of Claims, MDS and Staffing
-
Vertical Aerospace Announces First Half-Year 2022 Results
-
Form 6-K NOMURA HOLDINGS INC For: Aug 08
-
Work stoppages and no chatting at lunch: Japan Inc grapples with COVID
-
China July export growth seen cooling, imports likely to rise: Reuters poll
-
Sosei Heptares’ Oral, Selective M4 Receptor Agonist Advancing into Phase 2 Clinical Development under Multi-Program Collaboration with Neurocrine Biosciences

